SB 6-D, Florida's "Medical Freedom Act," prohibits vaccine manufacturers from offering financial incentives to healthcare practitioners for vaccine administration and requires practitioners to provide parents or legal guardians with specified materials before vaccinating minor children. The bill repeals a provision related to future repeal of messenger RNA vaccine definitions and establishes requirements for informed consent documentation. The measure takes effect July 1, 2026, with certain provisions tied to regulatory adoption timelines by Florida's medical boards.

Why It Matters to MAHA

This bill directly advances health freedom and patient autonomy by strengthening informed consent requirements and removing financial incentive structures that MAHA supporters argue create conflicts of interest in medical decision-making. By mandating that parents receive specified materials before vaccine administration, the bill empowers families to make healthcare choices based on complete information rather than relying solely on provider recommendations potentially influenced by financial arrangements. The prohibition on manufacturer incentive payments aligns with MAHA's transparency principle by reducing hidden financial relationships between pharmaceutical companies and practitioners. Removing these financial barriers to genuine informed consent represents a significant step toward restoring trust in the patient-provider relationship and ensuring medical decisions are driven by patient preference rather than practitioner compensation.